Vogenx, Inc. (VOGX)
29.36
-3.14
(-9.66%)
USD |
NASDAQ |
Sep 21, 16:00
29.36
0.00 (0.00%)
After-Hours: 20:00
Vogenx Enterprise Value : 483.47M for Sept. 18, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 18, 2026 | 483.47M |
| September 17, 2026 | 507.68M |
| September 16, 2026 | 496.69M |
| September 15, 2026 | 479.16M |
| September 14, 2026 | 482.28M |
| September 11, 2026 | 486.59M |
| September 10, 2026 | 444.25M |
| September 09, 2026 | 443.36M |
| September 08, 2026 | 476.04M |
| September 04, 2026 | 472.03M |
| September 03, 2026 | 478.27M |
| September 02, 2026 | 477.52M |
| September 01, 2026 | 492.82M |
| August 31, 2026 | 505.75M |
| Date | Value |
|---|---|
| August 28, 2026 | 505.15M |
| August 27, 2026 | 500.25M |
| August 26, 2026 | 489.11M |
| August 25, 2026 | 469.06M |
| August 24, 2026 | 457.17M |
| August 21, 2026 | 439.20M |
| August 20, 2026 | 352.00M |
| August 19, 2026 | 344.72M |
| August 18, 2026 | 294.06M |
| August 17, 2026 | 234.64M |
| August 14, 2026 | 220.23M |
| August 13, 2026 | 209.98M |
| August 12, 2026 | 193.79M |
| August 11, 2026 | 193.79M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| IGC Pharma, Inc. | 29.92M |
| Cocrystal Pharma, Inc. | 15.78M |
| CNBX Pharmaceuticals, Inc. | 1.313M |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | -18.36M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.3844M |
| Total Expenses (Quarterly) | 0.3844M |
| EPS Diluted (Quarterly) | -0.0259 |
| Earnings Yield | -0.35% |
| Normalized Earnings Yield | -0.3440 |